New Jersey Medical School Clinical Research Center is the only site in the state participating in a worldwide effort to enroll 3,800 HIV negative individuals in the first Phase 3 HIV vaccine efficacy trial conducted in more than a decade. To read the full article.
Recent Posts
- Rutgers Launches Center to Tackle Barriers to Weight Loss and Other Causes of Disease.
- Join NJ ACTS Biostatistics, Epidemiology, Research Design (BERD) on 4/24 at 1pm for a Workshop
- Rutgers Health Researchers Reveal Health Care Disparities for People with Disabilities.
- Rutgers Researchers Revive Decades-Old Pregnancy Cohort with Modern Scientific Potential.
- Rutgers Researchers Revive Decades-Old Pregnancy Cohort with Modern Scientific Potential.
Categories
- Community (2,198)
- Covid (983)
- CTO Events (6)
- News (2,806)
- Pilots (21)